Concepedia

Author

Jan Feyzi

University of Wisconsin–Madison

Also Known As

J Feyzi, J. Feyzi, J. M. FEYZI, J. M. Feyzi, Jan Feyzi, Jan M. Feyzi

23

Publications

3.3K

Citations

13

H-Index

30

Concepts

All Affiliations

University of Wisconsin–MadisonWilliam S. Middleton Memorial Veterans HospitalUniversity of Wisconsin Carbone Cancer Center
JF

About

Jan Feyzi is an author at University of Wisconsin–Madison specializing in medicine, physiology, and endocrinology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

131

2

Endocrinology

3

3

105

3

Health Sciences

1

1

12

4

Social Sciences

1

1

71

5

Immunology

1

1

19

Jan Feyzi

×

14

Publications

3.3K

Citations

13

H-Index

YearCitations

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen,

New England Journal of Medicine

2009

2K

Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women

Richard R. Love, Donald A. Wiebe, Polly A. Newcomb,

Annals of Internal Medicine

1991

375

Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of Treatment

Richard R. Love, Donald A. Wiebe, Jan Feyzi,

JNCI Journal of the National Cancer Institute

1994

285

Metastatic basal cell carcinoma. Report of five cases

Stephen N. Snow, William J. Sahl, Jacob S. Lo,

Cancer

1994

228

Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials

Mardi Gomberg‐Maitland, Nanette K. Wenger, Jan Feyzi,

European Heart Journal

2006

103

Plasma Adrenocorticotropic Hormone in the Rat Demonstrates Three Different Rhythms within 24 h

Molly Carnes, Stephanie J. Lent, Jan Feyzi,

Neuroendocrinology

1989

71

Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data

Knut Gjesdal, Jan Feyzi, S. Bertil Olsson

Heart

2007

66

Intracavernous Self-Injection for Impotence: A Long-Term Therapeutic Option? Experience In 78 Patients

Forrest M. Girdley, Reginald C. Bruskewitz, Jan Feyzi,

The Journal of Urology

1988

46

RISK FACTORS FOR SENSITIZATION BY BLOOD TRANSFUSIONS. COMPARISON OF THE UW/MADISON AND UC/SAN FRANCISCO DONOR-SPECIFIC TRANSFUSION EXPERIENCE

W.J. Burlingham, Robert J. Stratta, Beth Mason,

Transplantation

1989

19

Immunoneutralization of corticotropin-releasing hormone prevents the diurnal surge of acth

Molly Carnes, Stephanie J. Lent, Susan Erisman,

Life Sciences

1989

19

Page 1